跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,943 条关于
“BET inhibitors”
全部
19,943
临床试验
10,697
药物
3,959
机构
88
资讯
5,199
2年前
Why BET Inhibitors Fail in Estrogen-Driven Breast Cancer and How to Improve Them
5个月前
BRD2 Emerges as Key Driver of BET Inhibitor Resistance Across Multiple Cancers
去年
VYNE Therapeutics Advances VYN201 and VYN202 in Vitiligo and Psoriasis Trials
上个月
VYNE Therapeutics and Yarrow Bioscience Merger Nears Completion: Cash Dividend Distributed, Reverse Stock Split Set, and YB-101 Poised to Advance Autoimmune Thyroid Disease Pipeline
3个月前
Nuvation Bio Director Buys 25,000 Shares as Taletrectinib Gains Global Regulatory Momentum
10个月前
Zenith Epigenetics' ZEN-3694 Receives FDA Orphan Drug Designation for NUT Carcinoma Treatment
去年
Vitiligo Treatment Pipeline Shows Promise with JAK Inhibitors and Novel Immunotherapies in Phase 3 Trials
去年
Jacobio Pharma Receives IND Acceptance for BET Inhibitor JAB-8263 in Autoimmune Diseases
4个月前
Chinese BET Inhibitor NHWD-870 Receives Breakthrough Therapy Designation for Rare NUT Carcinoma
去年
AbbVie's Emraclidine Fails in Phase 2 Schizophrenia Trials, $9B Acquisition Questioned
第 1 页,共 520 页
上一页
下一页